Licence Agreement between TopRidge Pharma Limited and AstraZeneca Pharma India Limited for IMDURLicensing Agreement • October 16th, 2017
Contract Type FiledOctober 16th, 2017THIS LICENSE AGREEMENT (hereinafter called "Agreement") is effective as of this _____ day of ___________ 2017 (hereinafter called "Effective Date"), between TopRidge Pharma Limited (formerly named as EVEREST FUTURE LIMITED), a corporation organised and existing under the law of Hong Kong (Registration No:2333670) and having its principal place of business at Unit A,11/F,Chung Pont Commercial Building,300 Hennessy Road, Wanchai, Hong Kong (hereinafter called "TP") of the one part, and AstraZeneca Pharma India Limited, a company incorporated in India under the Companies Act, 1956 (CIN No: L24231KA1979PLC003563) with its registered office address at Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bangalore – 560045 and member of the AstraZeneca Group (hereinafter called " AstraZeneca”).